Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
OPINION
Opioid litigants get boost from Senate report
By Bill Meagher
Feb 13, 2018 3:08 PM EST
PRESS RELEASES
Collegium To Host Conference Call To Discuss Third Quarter 2020 Financial Results And Provide Corporate Update
By GlobeNewswire
Oct 22, 2020 4:01 PM EDT
PRESS RELEASES
Collegium Announces Settlement With Teva Resolving Xtampza® ER Patent Litigation
By GlobeNewswire
Sep 30, 2020 8:00 AM EDT
PRESS RELEASES
Collegium Appoints Rita Balice-Gordon To Its Board Of Directors
By GlobeNewswire
Sep 25, 2020 8:00 AM EDT
PRESS RELEASES
Collegium To Host Conference Call To Discuss Second Quarter 2020 Financial Results And Provide Corporate Update
By GlobeNewswire
Jul 21, 2020 5:00 PM EDT
PRESS RELEASES
Collegium Pharmaceutical Named One Of Boston Business Journal's 2020 Best Places To Work
By GlobeNewswire
Jun 17, 2020 5:09 PM EDT
PRESS RELEASES
Collegium To Host Conference Call To Discuss First Quarter 2020 Financial Results And Provide Corporate Update
By GlobeNewswire
Apr 23, 2020 4:01 PM EDT
PRESS RELEASES
Collegium To Participate In Upcoming Investor Conference
By GlobeNewswire
Apr 7, 2020 4:01 PM EDT
PRESS RELEASES
Collegium To Host Conference Call To Discuss Fourth Quarter And Full-Year 2019 Financial Results And Provide Corporate Update
By GlobeNewswire
Feb 26, 2020 1:05 PM EST
PRESS RELEASES
Collegium Announces Closing Of The Nucynta Franchise Acquisition
By GlobeNewswire
Feb 13, 2020 4:01 PM EST
PRESS RELEASES
Collegium Pharmaceutical, Inc. Prices $125.0 Million Convertible Senior Notes Offering
By GlobeNewswire
Feb 10, 2020 7:15 PM EST
PRESS RELEASES
Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering
By GlobeNewswire
Feb 10, 2020 7:20 AM EST
PRESS RELEASES
Biohaven Appoints Michael Heffernan To Board Of Directors
By PR Newswire
Jan 31, 2020 5:00 PM EST
OPINION
Opioid litigants get boost from Senate report
By Bill Meagher
Feb 13, 2018 3:08 PM EST
MARKETS
Collegium Pharmaceutical (COLL) Stock Spikes on Positive FDA Committee Review
By Tony Owusu
Sep 14, 2015 11:21 AM EDT
